Union Budget 2025, to be presented on 1 February, is expected to focus on fuel price cuts, tax relief for the middle class, ...

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...

Biocon advanced 2.41% to Rs 397.20 after its board is scheduled to meet on Monday, 27 January 2025, to consider and approve the raising of funds on a private placement basis.

AM(IST)on Thursday in an upbeat market. Aurobindo Pharma Ltd.(up 3.29 per cent), Biocon Ltd.(up 2.23 per cent), Ipca Laboratories Ltd.(up 1.59 per cent), Granules India Ltd.(up 1.56 per cent) and ...

Biocon stock price is poised for a fresh breakout from its consolidation range of 320-395, following nearly three and a half ...

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

Biocon's chairperson urges India's government to exempt cancer and chronic disease drugs from taxes to alleviate patient ...

India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major ...

India should eliminate tax on drugs for cancer treatment and chronic diseases, urged Biocon's chairperson Kiran Mazumdar-Shaw ...

Shaw, chairperson of Biocon Ltd, urges the Indian government to eliminate taxes on drugs for cancer and chronic diseases.

Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar ...